본문으로 건너뛰기
← 뒤로

Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification.

International journal of colorectal disease 2025 Vol.40(1) p. 223

Saito A, Yokoyama Y, Uchino M, Ikeuchi H, Okabayashi K, Oka S, Higashi D, Ogawa S, Watanabe K, Shibutani M, Okita Y, Wakai T, Mizuuchi Y, Okamoto K, Yamada K, Sato Y, Ogino T, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Yamamoto T, Yamamoto S, Koyama F, Hanai T, Komori K, Shida D, Arakaki J, Fujita F, Yamaguchi S, Ueno H, Matsuda K, Maemoto A, Nezu R, Sasaki S, Sunami E, Noguchi T, Sugihara K, Ajioka Y, Ishihara S

📝 환자 설명용 한 줄

[PURPOSE] Few studies have reported the association of macroscopic classification with clinicopathological characteristics and prognosis of ulcerative colitis-associated colorectal cancer (UC-CRC), un

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value p < 0.01
  • HR 6.35

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Saito A, Yokoyama Y, et al. (2025). Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification.. International journal of colorectal disease, 40(1), 223. https://doi.org/10.1007/s00384-025-05001-w
MLA Saito A, et al.. "Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification.." International journal of colorectal disease, vol. 40, no. 1, 2025, pp. 223.
PMID 41152600

Abstract

[PURPOSE] Few studies have reported the association of macroscopic classification with clinicopathological characteristics and prognosis of ulcerative colitis-associated colorectal cancer (UC-CRC), unlike sporadic CRC. In this study, we aimed to clarify the clinical significance of macroscopic classification of UC-CRC.

[METHODS] The cohort included 480 patients with UC-CRC with invasion beyond the muscularis propria treated at 43 Japanese institutions between 1983 and 2023. The patients were divided into six groups based on the macroscopic type (types 0-5), and clinicopathological features and prognoses were compared.

[RESULTS] Among 480 patients, 66 (13.8%), 75 (15.6%), 116 (24.2%), 63 (13.1%), 68 (14.2%), and 92 (19.2%) had type 0-5 tumors, respectively. There were significant differences in the clinicopathological characteristics with a younger age in type 4 or 5 tumors than in type 2 tumors (p < 0.01) and a higher frequency of undifferentiated carcinomas (p < 0.01) and lymph node metastasis (p < 0.01) and more advanced depth of invasion (p < 0.01) in type 4 tumors than in type 1 or 2 tumors. Type 4 and 5 were independent risk factors for 5-year recurrence-free survival (p = 0.02; type 4 [HR: 6.35], type 5 [HR: 5.25]) and type 0, 4, and 5 for overall survival (p = 0.02; type 0 [HR: 4.51], type 4 [HR: 5.70], type 5 [HR: 4.02]).

[CONCLUSIONS] Type 0, 4, and 5 tumors were characteristic macroscopic types of UC-CRC and correlated with worse prognosis. Therefore, endoscopic diagnosis of the macroscopic type of UC-CRC might be helpful in determining tumor aggressiveness.

MeSH Terms

Humans; Female; Male; Middle Aged; Colitis, Ulcerative; Adult; Aged; Colorectal Neoplasms; Prognosis; Treatment Outcome; Neoplasm Invasiveness; Disease-Free Survival; Risk Factors; Lymphatic Metastasis; Colitis-Associated Neoplasms

같은 제1저자의 인용 많은 논문 (5)